Merrimack's Prospects Dim As MM-141 Fails Pancreatic Cancer Phase II Trial

 
• By Sten Stovall
  
Pancreatic cancer
MM-141 Missed Endpoints In CARRIE Phase II Trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D